Sarbanes-Oxley overburdens biotech companies

Article metrics

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Author information

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Kessel, M. Sarbanes-Oxley overburdens biotech companies. Nat Biotechnol 29, 1081–1082 (2011) doi:10.1038/nbt.2059

Download citation